Inhibitory effects of curcumin on high glucose-induced damages: Implications for alleviating diabetic complications
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hyperglycemia found in diabetes mellitus causes several physiological abnormalities including the formation of advanced glycation end products (AGEs) and oxidative stress. Accumulation of AGEs and elevation of oxidative stress plays major roles in the development of diabetic complications. Adiponectin secreted from adipocytes is known to improve insulin sensitivity and blood glucose level. Curcumin (CCM), a bioactive component of turmeric, has been reported as a potent antioxidant. Present work aimed to elucidate the roles of CCM in high glucose-induced protein glycation and intracellular events in mature adipocytes. The results demonstrated that CCM inhibited the formation of fluorescent AGEs by approximated 52% at 3 weeks of bovine serum albumin (BSA) glycation with glucose. Correspondingly, CCM decreased the levels of fructosamine and α-dicarbonyl compounds during BSA glycation with glucose. These data suggested that CCM might be a new promising anti-glycation agent. Also, CCM reduced high glucose-induced oxidative stress in a dose dependent manner, whereas CCM treatment time-dependently elevated the expression of adiponectin gene in 3T3-L1 adipocytes. The findings from this study suggested the possibility of therapeutic use of CCM for the prevention of diabetic complications and obesity-related diseases.
Abstract
Hyperglycemia found in diabetes mellitus causes several physiological abnormalities including the formation of advanced glycation end products (AGEs) and oxidative stress. Accumulation of AGEs and elevation of oxidative stress plays major roles in the development of diabetic complications. Adiponectin secreted from adipocytes is known to improve insulin sensitivity and blood glucose level. Curcumin (CCM), a bioactive component of turmeric, has been reported as a potent antioxidant. Present work aimed to elucidate the roles of CCM in high glucose-induced protein glycation and intracellular events in mature adipocytes. The results demonstrated that CCM inhibited the formation of fluorescent AGEs by approximated 52% at 3 weeks of bovine serum albumin (BSA) glycation with glucose. Correspondingly, CCM decreased the levels of fructosamine and α-dicarbonyl compounds during BSA glycation with glucose. These data suggested that CCM might be a new promising anti-glycation agent. Also, CCM reduced high glucose-induced oxidative stress in a dose dependent manner, whereas CCM treatment time-dependently elevated the expression of adiponectin gene in 3T3-L1 adipocytes. The findings from this study suggested the possibility of therapeutic use of CCM for the prevention of diabetic complications and obesity-related diseases.
참고문헌 (25)
- Brownlee M, "Biochemistry and molecular cell biology of diabetic complications", Nature, 414, pp.813~820 (2001)
- Giacco F, "Oxidative stress and diabetic complications", Circ Res, 107, pp.1058~1070 (2010)
- Finkel T, "Oxidants, oxidative stress and the biology of ageing", Nature, 408, pp.239~247 (2000)
- Yan SD, "Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors", binding proteins, 1994, pp.269, 9889~9897
- Zhang Q, "A perspective on the Maillard reaction and the analysis of protein glycation by mass", J Proteome Res, 8, pp.754~769 (2009)
- Neelofar K, "Hyperglycemia induced structural and functional changes in human serum albumin of diabetic patients: a physico-chemical study", Mol Biosyst, 12, pp.2481~2489 (2016)
- Weyer C, "Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia", J Clin Endocrinol Metab, 86, pp.1930~1935 (2001)
- Hu E, "AdipoQ is a novel adipose-specific gene dysregulated in obesity", J Biol Chem, 271, pp.10697~10703 (1996)
- Yamauchi T, "The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity", Nat Med, 7, pp.941~946 (2001)
- Nakagawa T, "Protective activity of green tea against free radical-and glucose-mediated protein damage", J Agric Food Chem, 50, pp.2418~2422 (2002)
- Vinson JA, "Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients", The J Nutr Biochem, 7, pp.659~663 (1996)
- Shishodia S, "Curcumin : Getting back to the roots", Ann N Y Acad Sci, 1056, pp.206~217 (2005)
- Anand P, "Biological activities of curcumin and its analogues(Congeners)made by man and Mother Nature", Biochem Pharmacol, 76, pp.1590~1611 (2008)
- Kim CY, "Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion", J Nutr Biochem, 22, pp.910~920 (2011)
- Wu JW, "Inhibitory effects of guava(Psidium guajava L. )leaf extracts and its active compounds on the glycation process of protein", Food Chem, 113, pp.78~84 (2009)
- Mitchel R, "The use of Girard-T reagent in a rapid and sensitive method for measuring glyoxal and certain other α-dicarbonyl compounds", Anal Biochem, 81, pp.47~56 (1977)
- Chen CY, "An advanced glycation end product(AGE)-receptor for AGEs(RAGE)axis restores adipogenic potential of senescent preadipocytes through modulation of p53 protein function", J Biol Chem, 287, pp.44498~44507 (2012)
- Kim CY, "Modification of curcumin with polyethylene glycol enhances the delivery of curcumin in preadipocytes and its antiadipogenic property", J Agric Food Chem, 59, pp.1012~1019 (2011)
- Keen H, "Early closure of European Pimagedine trial", Lancet, 350, pp.214~215 (1997)
- Thilavech T, "Protective effects of cyanidin-3-rutinoside against monosaccharides-induced protein glycation and oxidation", Int J Biol Macromol, 75, pp.515~520 (2015)
- Wang J, "Protein glycation inhibitory activity of wheat bran feruloyl oligosaccharides", Food Chem, 112, pp.350~353 (2009)
- Evert AB, "Nutrition therapy recommendations for the management of adults with diabetes", Diabetes Care, 36, pp.3821~3842 (2013)
- Kadowaki T, "Adiponectin and adiponectin receptors", Endocr Rev, 26, pp.439~451 (2005)
- Hassan M, "Phloretin enhances adipocyte differentiation and adiponectin expression in 3T3-L1 cells", Biochem Biophys Res Commun, 361, pp.208~213 (2007)
- Sharma AK, "Up-regulation of PPARγ, heat shock protein-27 and-72 by naringin attenuates insulin resistance, β-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes", Br J Nutr, 106, pp.1713~1723 (2011)